Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESRichard Lennox Named COO of Current Health

Richard Lennox Named COO of Current Health

Richard Lennox has been appointed Chief Operating Officer of Current Health. The news was announced today. The company reports Lennox is an experienced business leader with a reputation for helping tech startups accelerate hypergrowth, will develop and implement the company’s strategic approach to growth, and oversee product development.

Lennox was a principal at Original Angle, a high-growth consultancy, and spent more than eight years in senior leadership roles at Skyscanner. He was integral in Skyscanner’s rapid growth to 70 million monthly global travelers. Before being acquired for £1.4 billion in 2016, Skyscanner had more than 950 employees in over 10 offices worldwide and more than £150 million in annual revenue.

“Following an amazing growth journey at Skyscanner, and subsequently supporting a range of growing technology organisations, I wanted to bring that experience to focus on a single, impactful, product-led organisation,“ said Richard Lennox, COO of Current Health. “Saving and preserving the quality of people’s lives is definitely impactful and I wholeheartedly believe that’s what our product does. What the Current Health team has achieved to date is exemplary, and I’m honoured to help take this great company to the next level, while also continuing to elevate Edinburgh and Scotland’s thriving tech sector.”

Current Health is partnering with six of the U.S.’s largest health systems, including Mount Sinai and Banner Health, and several NHS Trusts in the U.K. to help reduce hospital readmissions and enable better patient outcomes. Its wearable device and platform continuously track more vital signs with ICU-level accuracy than any other available device, offering a complete view of patient health and precise warning alerts so clinicians can intervene early.

“Richard’s remarkable talent for scaling companies makes him the right choice to help us accelerate and propel our team forward,” Christopher McCann, CEO and co-founder of Current Health. “Since receiving our CE marking here in the U.K. and two FDA clearances in the U.S., we’re experiencing incredible growth and interest from top healthcare systems around the world. We need a talented business leader to implement sound strategies for sustainable growth while overseeing our product development, and we’re thrilled that Richard has joined us.”

Current Health’s wearable was designed with the patient in mind. It has over a 90% patient adherence rate, and they report feeling safer and more secure wearing it. CE-marked in the U.K. and FDA-cleared for both in-hospital and post-acute care in the U.S., Current Health was developed using one of the world’s largest physiological data sets with more than 30,000 patient hours. Its proprietary algorithms continuously analyze data to help predict a patient’s health trajectory by detecting indicators of decline earlier for faster intervention, better outcomes, and fewer preventable deaths.

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy